AngioSafe
CA - San JoseBiotechnology
Focus: AngioSafe is a cardio-intervention device company focused on peripheral artery occlusion treatment through minimally invasive crossing systems. The company operates as a specialized medical device biotechnology firm based in San Jose, California.
Profile data last refreshed 2h ago · AI intelligence enriched 3w ago
Open Jobs
5+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at AngioSafe?
AI assessmentAngioSafe offers early-stage device commercialization upside for risk-tolerant professionals, but extreme data opacity on funding and financials demands serious diligence before committing.
Why Work Here
- Early-stage device innovation in high-need cardiovascular market with only one active clinical trial suggesting focused product development
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AngioSafe Peripheral CTO Crossing System
Peripheral Artery OcclusionClinical Trials (1)
NCT04663867AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study)
N/AHelp build intelligence for AngioSafe
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.